Cover Image
市場調查報告書

胸部主動脈覆膜支架:醫療設備的開發平台評估

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358226
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
胸部主動脈覆膜支架:醫療設備的開發平台評估 Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年05月23日 內容資訊: 英文 50 Pages
簡介

本報告提供全球胸部主動脈覆膜支架市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品功能·特性比較分析 (臨床實驗的各進展階段) ,還有主要企業簡介及代表性產品,彙整近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 胸部主動脈覆膜支架概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 胸部主動脈覆膜支架的企業:各臨床實驗階段的開發中產品
  • 胸部主動脈覆膜支架:各臨床實驗階段的開發中產品

第5章 胸部主動脈覆膜支架市場:企業·產品概要

  • Cook Medical Incorporated
  • Evasc Medical Systems Corp.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • TriVascular, Inc.
  • W. L. Gore & Associates, Inc.

第6章 胸部主動脈覆膜支架市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0189EPD

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016" provides an overview of Thoracic Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thoracic Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Thoracic Aortic Stent Grafts Overview

3. Products under Development

  • 3.1. Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2. Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3. Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4. Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5. Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4. Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1. Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2. Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5. Thoracic Aortic Stent Grafts Companies and Product Overview

  • 5.1. Cook Medical Incorporated Company Overview
    • 5.1.1. Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Evasc Medical Systems Corp. Company Overview
    • 5.2.1. Evasc Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Medtronic plc Company Overview
    • 5.3.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. MicroPort Scientific Corporation Company Overview
    • 5.4.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. St. Jude Medical, Inc. Company Overview
    • 5.5.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. TriVascular, Inc. Company Overview
    • 5.6.1. TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. W. L. Gore & Associates, Inc. Company Overview
    • 5.7.1. W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1. Apr 28, 2016: Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
  • 6.2. Feb 22, 2016: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2015
  • 6.3. Jan 26, 2016: First U.S. patient treated following FDA approval of Cook Medical's Zenith Alpha Thoracic Endovascular Graft
  • 6.4. Nov 06, 2015: Merit Medical Names New Chief Financial Officer
  • 6.5. Nov 02, 2015: Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015
  • 6.6. Oct 22, 2015: Merit Medical Announces Results for the Quarter Ended September 30, 2015
  • 6.7. Sep 17, 2015: Cook Medical receives FDA approval for the Zenith Alpha Thoracic Endovascular Graft
  • 6.8. Jul 23, 2015: Merit Medical Reports Record Revenues for the Quarter and Six Months Ended June 30, 2015

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Table 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Table 4: Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Table 5: Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
  • Table 6: Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Table 7: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 8: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Zenith TX2 LP TAA Endovascular Graft - Product Status
  • Table 10: Zenith TX2 LP TAA Endovascular Graft - Product Description
  • Table 11: Cook Medical Incorporated - Ongoing Clinical Trials Overview
  • Table 12: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile Endovascular Graft for Blunt Thoracic Aortic Injury (TRANSFIX)
  • Table 13: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile TAA Endovascular Graft Clinical Study
  • Table 14: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile TAA Endovascular Graft Clinical Study
  • Table 15: Evasc Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: TAS System - Product Status
  • Table 17: TAS System - Product Description
  • Table 18: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Valiant EVO - Product Status
  • Table 20: Valiant EVO - Product Description
  • Table 21: Valiant Mona LSA System - Product Status
  • Table 22: Valiant Mona LSA System - Product Description
  • Table 23: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 24: Valiant Mona LSA System - Valiant Mona LSA Stent Graft System Early Feasibility Study
  • Table 25: Valiant Mona LSA System - Valiant Mona LSA Thoracic Stent Graft System Feasibility Study
  • Table 26: Valiant EVO - Valiant Evo International Clinical Trial
  • Table 27: Valiant EVO - Valiant Evo US Clinical Trial
  • Table 28: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Castor Branched Stent Graft System - Product Status
  • Table 30: Castor Branched Stent Graft System - Product Description
  • Table 31: Hercules - LP - Product Status
  • Table 32: Hercules - LP - Product Description
  • Table 33: MicroPort Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 34: Castor Branched Stent Graft System - A Multi-center Trial of Castor Single-Branched Stent Graft System for Endovascular Repair of Aortic Dissection
  • Table 35: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Amplatzer TAA Vascular Graft - Product Status
  • Table 37: Amplatzer TAA Vascular Graft - Product Description
  • Table 38: TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Ovation Thoracic Stent Graft System - Product Status
  • Table 40: Ovation Thoracic Stent Graft System - Product Description
  • Table 41: W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: GORE TAG Thoracic Branch Endoprosthesis - Product Status
  • Table 43: GORE TAG Thoracic Branch Endoprosthesis - Product Description
  • Table 44: W. L. Gore & Associates, Inc. - Ongoing Clinical Trials Overview
  • Table 45: GORE TAG Thoracic Branch Endoprosthesis - GORE TAG Thoracic Branch Endoprosthesis Early Feasibility Study
  • Table 46: Glossary

List of Figures

  • Figure 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Figure 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Figure 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Figure 4: Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Figure 5: Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
Back to Top